2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years). -н Zienab M. Saad (22676502)

Нөхцлүүд:

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years). -н Zienab M. Saad (22676502)

Нөхцлүүд:

eGFR in the study participants. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Demographic and Clinical Characteristics of Study Participants. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Stratification of Liver Stiffness according to eGFR in the MAFLD group. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Medication-inclusive multivariable logistic regression for MAFLD. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Comparison of Non-invasive Liver Fibrosis Scores. -н Zienab M. Saad (22676502)

Нөхцлүүд:

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Proposed pathophysiological crosstalk between MAFLD and CKD. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Liver Stiffness and Fibrosis Grading by MAFLD Status. -н Zienab M. Saad (22676502)

Нөхцлүүд:

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). -н Zienab M. Saad (22676502)

Нөхцлүүд:

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). -н Zienab M. Saad (22676502)

Нөхцлүүд:

Multivariable logistic regression models for MAFLD predictors. -н Zienab M. Saad (22676502)

Нөхцлүүд:

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). -н Zienab M. Saad (22676502)

Нөхцлүүд: